Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT

Affiliations

• ¹ Hannover Medical School, Hannover, Germany. koenecke.christian@mh-hannover.de.
• ² EBMT statistical Unit, Leiden, The Netherlands.
• ³ EBMT data office Leiden, Leiden, The Netherlands.
• ⁴ Universitätsklinikum Essen, Essen, Germany.
• ⁵ GKT School of Medicine, London, UK.
• ⁶ University Hospital Eppendorf, Hamburg, Germany.
• ⁷ University Hospital TU Dresden, Dresden, Germany.
• ⁸ University of Freiburg, Freiburg, Germany.
• ⁹ University Hospital Leipzig, Leipzig, Germany.
• ¹⁰ University of Heidelberg, Heidelberg, Germany.
• ¹¹ Hannover Medical School, Hannover, Germany.
• ¹² HUCH Comprehensive Cancer Center, Helsinki, Finland.
• ¹³ Institut Paoli-Calmettes, Marseille, France.
• ¹⁴ Heinrich Heine Universitaet, Duesseldorf, Germany.
• ¹⁵ Vrije Universiteit Medical center, Amsterdam, The Netherlands.
• ¹⁶ Rigshospitalet, Copenhagen, Denmark.
• ¹⁷ University Hospital Gasthuisberg, Leuven, Belgium.
• ¹⁸ Hospital Clinico, Salamanca, Spain.
• ¹⁹ Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
• ²⁰ Azienda Ospedali Riuniti di Ancona, Ancona, Italy.
• ²¹ Ankara Sehir Hastanesi, Ankara, Turkey.
• ²² Trinity College Dublin, St. James's Hospital, Dublin, Ireland.
• ²³ Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico-University of Milan, Milan, Italy.
• ²⁴ Hopital St. Louis, Paris, France.
• ²⁵ CHU de Lille, INSERM U1286, Infinite, Université de Lille, 59000, Lille, France.